Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

23.10

+0.70

(+3.13%)

At close: 04:00PM EDT

23.00

-0.10

(-0.43%)

After hours:

07:57PM EDT

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Simply Wall St.
While Fate Therapeutics (NASDAQ:FATE) shareholders have made 502% in 5 years, increasing losses might now be front of mind as stock sheds 15% this week
Fate Therapeutics, Inc. ( NASDAQ:FATE ) shareholders might understandably be very concerned that the share price has...
GlobeNewswire
Fate Therapeutics to Present at Upcoming May Investor Conferences
SAN DIEGO, May 06, 2022 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that the Company will present at the following upcoming investor conferences: BofA Securities 2022 Healthcare Conference on Thursday, May 12, 2022 at 12:20 PM ET in Las Vegas, NevadaH.C. Wainwright Annual Global Life Science
Zacks
FATE's Loss Narrower Than Expected in Q1, Pipeline in Focus
FATE reports a narrower loss and higher collaboration revenues in the first quarter.

Advertisement